We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GUIDANCE SPELLS OUT WHEN FDA WILL ENGAGE INDEPENDENT CONSULTANT
GUIDANCE SPELLS OUT WHEN FDA WILL ENGAGE INDEPENDENT CONSULTANT
August 20, 2004
A guidance document released by the FDA instructs clinical
trial sponsors on when and how to request that the agency engage
an independent consultant to participate in reviewing clinical studies, which serve as the primary basis of efficacy claims.